New COVID-19 variants BA.2.86 and RF.5: Symptoms, risks, and what you need to know

New COVID-19 variants BA.2.86 and RF.5 spread easily but remain mostly mild; experts advise vigilance, timely testing, ...

The F.D.A. Could Clear These Peptides. Here’s What the Research on Them Shows.

The agency is considering whether compounding pharmacies should be allowed to produce BPC-157, TB-500 and other previously ...

BioNTech's Next Act Has Nothing to Do With COVID. Here's the $500 Billion Market Some Investors Are Ignoring

BioNTech's oncology pipeline could help it make a dent in this large and growing market. However, there is one thing investors should consider before initiating a position. The weight-loss market is ...

Genmab and AbbVie Provide Clarification on Phase 3 EPCORE® DLBCL-1 Trial Evaluating Epcoritamab (DuoBody®-CD3xCD20) in Patients with Relapsed/Refractory Diffuse Large B-cell ...

People with DLBCL or high-grade B-cell lymphoma may be hospitalized after receiving their first full dose of EPKINLY on Day 15 of Cycle 1 due to the risk of CRS and neurologic problems. People with FL ...